The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study

被引:12
|
作者
Shafer, Leigh Anne [1 ,2 ]
Nsubuga, Rebecca N. [2 ]
Chapman, Ruth [3 ]
O'Brien, Katie [3 ]
Mayanja, Billy N. [2 ]
White, Richard G. [3 ]
机构
[1] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3E 3P5, Canada
[2] Uganda Virus Res Inst, Med Res Council Unit AIDS, Entebbe, Uganda
[3] London Sch Hyg & Trop Med, London WC1, England
基金
英国医学研究理事会;
关键词
RURAL-POPULATION; INFECTION; TRANSMISSION; PREVENTION; RISK; INTERVENTIONS; PREVALENCE;
D O I
10.1136/sextrans-2013-051219
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives Antiretroviral therapy (ART) availability in a population may influence risky sexual behaviour. We examine the potential impact of ART on the HIV epidemic, incorporating evidence for the impact that ART may have on risky sexual behaviour. Methods A mathematical model, parameterised using site-specific data from Uganda and worldwide literature review, was used to examine the likely impact of ART on HIV epidemiologic trends. We varied assumptions about rates of initiating ART, and changes in sexual partner turnover rates. Results Modelling suggests that ART will reduce HIV incidence over 20 years, and increase prevalence. Even in the optimistic scenario of ART enrollment beginning after just five months of infection (in HIV stage 2), prevalence is estimated to rise from a baseline of 10.5% and 8.3% among women and men, respectively, to at least 12.1% and 10.2%, respectively. It will rise further if sexual disinhibition occurs or infectiousness while on ART is slightly higher (2% female to male, rather than 0.5%). The conditions required for ART to reduce prevalence over this period are likely too extreme to be achievable. For example, if ART enrolment begins in HIV stage 1 (within the first 5 months of infection), and if risky sexual behaviour does not increase, then 3 of our 11 top fitting results estimate a potential drop in HIV prevalence by 2025. If sexual risk taking rises, it will have a large additional impact on expected HIV prevalence. Prevalence will rise despite incidence falling, because ART extends life expectancy. Conclusions HIV prevalence will rise. Even small increases in partner turnover rates will lead to an additional substantial increase in HIV prevalence. Policy makers are urged to continue HIV prevention activities, including promoting sex education, and to be prepared for a higher than previously suggested number of HIV infected people in need of treatment.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 50 条
  • [41] Impact of immediate initiation of antiretroviral therapy among men who have sex with men infected with HIV in Chengdu, southwest China: trends analysis, 2008-2018
    Wu, Chenyao
    Zhang, Baiyang
    Dai, Zhen
    Zheng, Qianwen
    Duan, Zhenhua
    He, Qinying
    Zhu, Cairong
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [42] Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study
    Barnabas, Ruanne V.
    van Rooyen, Heidi
    Tumwesigye, Elioda
    Murnane, Pamela M.
    Baeten, Jared M.
    Humphries, Hilton
    Turyamureeba, Bosco
    Joseph, Philip
    Krows, Meighan
    Hughes, James P.
    Celum, Connie
    LANCET HIV, 2014, 1 (02): : E68 - E76
  • [43] The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa
    Kaye, Dan Kabonge
    Kakaire, Othman
    Osinde, Michael Odongo
    Lule, John Chrysotom
    Kakande, Nelson
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2013, 7 (06): : 436 - 447
  • [44] Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy
    Hanna, David B.
    Jung, Molly
    Xue, Xiaonan
    Anastos, Kathryn
    Cocohoba, Jennifer M.
    Cohen, Mardge H.
    Golub, Elizabeth T.
    Hessol, Nancy A.
    Levine, Alexandra M.
    Wilson, Tracey E.
    Young, Mary A.
    Kaplan, Robert C.
    AIDS PATIENT CARE AND STDS, 2016, 30 (10) : 445 - 454
  • [45] Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys
    Abongomera, George
    Kiwuwa-Muyingo, Sylvia
    Revill, Paul
    Chiwaula, Levison
    Mabugu, Travor
    Phillips, Andrew N.
    Katabira, Elly
    Chan, Adrienne K.
    Gilks, Charles
    Musiime, Victor
    Hakim, James
    Kityo, Cissy
    Colebunders, Robert
    Gibb, Diana M.
    Seeley, Janet
    Ford, Deborah
    INTERNATIONAL HEALTH, 2017, 9 (02): : 91 - 99
  • [46] Septicaemia in a population-based HIV clinical cohort in rural Uganda, 1996-2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy
    Mayanja, B. N.
    Todd, J.
    Hughes, P.
    Van der Paal, L.
    Mugisha, J. O.
    Atuhumuza, E.
    Tabuga, P.
    Maher, D.
    Grosskurth, H.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (06) : 697 - 705
  • [47] Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based study
    Alvaro-Meca, Alejandro
    Ryan, Pablo
    Micheloud, Dariela
    De Miguel, Angel
    Berenguer, Juan
    Resino, Salvador
    SCIENTIFIC REPORTS, 2018, 8
  • [48] Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study
    Nosyk, Bohdan
    Zang, Xiao
    Min, Jeong E.
    Krebs, Emanuel
    Lima, Viviane D.
    Milloy, M-J
    Shoveller, Jean
    Barrios, Rolando
    Harrigan, P. Richard
    Kerr, Thomas
    Wood, Evan
    Montaner, Julio S. G.
    LANCET HIV, 2017, 4 (07): : E303 - E310
  • [49] Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda
    Kiwanuka, Julius
    Waila, Jacinta Mukulu
    Kahungu, Methuselah Muhindo
    Kitonsa, Jonathan
    Kiwanuka, Noah
    PLOS ONE, 2020, 15 (04):
  • [50] Impact of Antiretroviral Therapy on Incidence of Pregnancy among HIV-Infected Women in Sub-Saharan Africa: A Cohort Study
    Myer, Landon
    Carter, Rosalind J.
    Katyal, Monica
    Toro, Patricia
    El-Sadr, Wafaa M.
    Abrams, Elaine J.
    PLOS MEDICINE, 2010, 7 (02)